Goldman Sachs Group Inc Dr Reddys Laboratories LTD Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,559,128 shares of RDY stock, worth $119 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,559,128
Previous 1,837,163
15.13%
Holding current value
$119 Million
Previous $128 Million
10.54%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding RDY
# of Institutions
242Shares Held
23.6MCall Options Held
25.2KPut Options Held
8.5K-
Black Rock Inc. New York, NY2.18MShares$166 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A62.16MShares$165 Million0.04% of portfolio
-
Robeco Institutional Asset Management B.V.1.97MShares$150 Million0.32% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.93MShares$147 Million0.22% of portfolio
-
Aikya Investment Management LTD London, X01.24MShares$94.5 Million33.3% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.6B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...